Katerina Grafanaki

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 13

Top Topics

Disease Activity

Silver Nanoparticles

Atopic Dermatitis

Top Venues

Journal of clinical medicine

BMJ case reports

Dermatologic therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Katerina Grafanaki, Charalabos Antonatos, Alexandros Maniatis, Antonia Petropoulou, Eleftheria Vryzaki, Yiannis Vasilopoulos, Sophia Georgiou, Stamatios Gregoriou
Intrinsic Effects of Exposome in Atopic Dermatitis: Genomics, Epigenomics and Regulatory Layers. Journal of clinical medicine 12 (12) (2023)
Katerina Grafanaki, Angelina Bania, Eleni G Kaliatsi, Eleftheria Vryzaki, Yiannis Vasilopoulos, Sophia Georgiou
The Imprint of Exposome on the Development of Atopic Dermatitis across the Lifespan: A Narrative Review. Journal of clinical medicine 12 (6) (2023)
Katerina Grafanaki, Angelina Bania, Eleni G Kaliatsi, Eleftheria Vryzaki, Yiannis Vasilopoulos, Sophia Georgiou
The Imprint of Exposome on the Development of Atopic Dermatitis across the Lifespan: A Narrative Review. Journal of clinical medicine 12 (6) (2023)
Katerina Grafanaki, Angelina Bania, Eleni G Kaliatsi, Eleftheria Vryzaki, Yiannis Vasilopoulos, Sophia Georgiou
The Imprint of Exposome on the Development of Atopic Dermatitis across the Lifespan: A Narrative Review. Journal of clinical medicine 12 (6) (2023)
Katerina Grafanaki, Charalabos Antonatos, Alexandros Maniatis, Antonia Petropoulou, Eleftheria Vryzaki, Yiannis Vasilopoulos, Sophia Georgiou, Stamatios Gregoriou
Intrinsic Effects of Exposome in Atopic Dermatitis: Genomics, Epigenomics and Regulatory Layers. Journal of clinical medicine 12 (12) (2023)
Charalabos Antonatos, Katerina Grafanaki, Paschalia Asmenoudi, Panagiotis Xiropotamos, Paraskevi Nani, Georgios K Georgakilas, Sophia Georgiou, Yiannis Vasilopoulos
Contribution of the Environment, Epigenetic Mechanisms and Non-Coding RNAs in Psoriasis. Biomedicines 10 (8) (2022)
Katerina Grafanaki, Spyridon Lygeros, Alexandros Spyridonidis, Maria Liga
Tongue graft-versus-host disease: remission with ruxolitinib. BMJ case reports 15 (5) (2022)
Charalabos Antonatos, Aikaterini Patsatsi, Efterpi Zafiriou, Eleana F Stavrou, Andreas Liaropoulos, Aikaterini Kyriakoy, Evangelos Evangelou, Danai Digka, Angeliki Roussaki-Schulze, Dimitris Sotiriadis, Sophia Georgiou, Katerina Grafanaki, Nicholas K Moschonas, Yiannis Vasilopoulos
Protein network and pathway analysis in a pharmacogenetic study of cyclosporine treatment response in Greek patients with psoriasis. The pharmacogenomics journal (2022)
Katerina Grafanaki, Spyridon Lygeros, Eleutheria Maria Vryzaki, Sophia Georgiou
Rare vardenafil-associated Stevens-Johnson syndrome: toxic epidermal necrolysis. BMJ case reports 15 (2) (2022)
Kerasia-Maria Plachouri, Francesk Mulita, Katerina Grafanaki, Sophia Georgiou
Remission of genital and generalised extragenital lichen sclerosus et atrophicus under pulse therapy with intravenous steroids. BMJ case reports 14 (4) (2021)
Katerina Grafanaki, Alexandra Kourakli, Ilias Skeparnias, Theofanis Spiliopoulos, Dimitra Koumoundourou, Vasiliki Bravou, Angelos Alexopoulos, Argiris Symeonidis, Sophia Georgiou
Rare lobular capillary hemangioma associated with azacitidine in high-risk myelodysplastic syndrome patient. Dermatologic therapy 34 (2) (2021)
Katerina Grafanaki, Eleftheria Vryzaki, Sophia Georgiou, Maria Liga
Double trouble: Influenza and pneumococcal vaccine exacerbation of psoriasis in a new-onset polycythemia vera patient. The Journal of dermatology 47 (7) (2020)
Ilias Skeparnias, Dimitrios Anastasakis, Katerina Grafanaki, George Kyriakopoulos, Panagiotis Alexopoulos, Dimitrios Dougenis, Andreas Scorilas, Christos K Kontos, Constantinos Stathopoulos
Contribution of miRNAs, tRNAs and tRFs to Aberrant Signaling and Translation Deregulation in Lung Cancer. Cancers 12 (10) (2020)